Titel

Merkliste
1 Ergebnisse

Phase III trial of chemoradiotherapy with temozolomide plus..:

Lim, Michael ; Weller, Michael ; Idbaih, Ahmed...
info:eu-repo/semantics/altIdentifier/doi/10.1093/neuonc/noac116. , 2022

Link: https://hal.science/hal-04480061

RT Journal
T1 <Title>Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter</Title>

UL https://suche.suub.uni-bremen.de/peid=base-fthospicivilyon:oai:HAL:hal-04480061v1&Exemplar=1&LAN=DE
				
A1 Lim, Michael
A1 Weller, Michael
A1 Idbaih, Ahmed
A1 Steinbach, Joachim
A1 Finocchiaro, Gaetano
A1 Raval, Raju, R
A1 Ansstas, George
A1 Baehring, Joachim
A1 Taylor, Jennie, W
A1 Honnorat, Jerome
A1 Petrecca, Kevin
A1 de Vos, Filip
A1 Wick, Antje
A1 Sumrall, Ashley
A1 Sahebjam, Solmaz
A1 Mellinghoff, Ingo, K
A1 Kinoshita, Masashi
A1 Roberts, Mustimbo
A1 Slepetis, Ruta
A1 Warad, Deepti
A1 Leung, David
A1 Lee, Michelle
A1 Reardon, David, A
A1 Omuro, Antonio
PB HAL CCSD; Oxford University Press (OUP)
YR 2022
K1 MGMT promoter
K1 PD-L1
K1 glioblastoma
K1 nivolumab
K1 temozolomide
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology
K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
K1 [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
JF info:eu-repo/semantics/altIdentifier/doi/10.1093/neuonc/noac116
LK http://dx.doi.org/https://hal.science/hal-04480061
DO https://hal.science/hal-04480061
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)